Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, March 1999, p. 722-723, Vol. 43, No. 3
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
LETTERS TO THE EDITOR
Antimicrobial Susceptibility of Neisseria
gonorrhoeae in Fukuoka City, Japan, in the Early 1980s and
1997-1998: Emergence of High-Level Fluoroquinolone Resistance
 |
LETTER |
Resistance to fluoroquinolones in gonococcal isolates has recently
become a significant problem in Far East Asia including Japan
(2). In the present study, we examined the in vitro
antimicrobial susceptibilities of gonococcal isolates from 1997 to 1998 in Fukuoka City, Japan, to various agents, in order to investigate the
emergence of high-level fluoroquinolone resistance.
A total of 186 strains of Neisseria gonorrhoeae were
isolated from men with urethritis attending a sexually transmitted
diseases (STD) clinic in Fukuoka City from March 1997 through March
1998. Of the 186 isolates, 157 were included in this study, while the remaining 29 were from patients known to have received fluoroquinolones or other antibiotics and were excluded. For comparative purposes, antimicrobial susceptibilities of 27 N. gonorrhoeae strains,
14
-lactamase producing and 13 not
-lactamase producing, that
were urethral isolates obtained at an STD clinic in the city between 1981 and 1984 were also tested. The MICs for all isolates were determined by an agar dilution technique and twofold dilutions of
antibiotic (2). The criterion for high-level ciprofloxacin resistance in N. gonorrhoeae isolates was a MIC of 1 to 16 µg/ml (1). There are no established criteria that define
resistance to other fluoroquinolones. Therefore, we set the criteria
for high-level resistance as follows:
2 µg/ml for norfloxacin,
0.5 µg/ml for levofloxacin,
0.5 µg/ml for sparfloxacin, and
0.25 µg/ml for DU-6859a. The proportions of strains from
1997-1998 with high-level resistance to the five fluoroquinolones were
compared with those of strains from 1981 to 1984 by the chi-square test.
Of the 157 strains from 1997-1998, 37 (23.6%) showed high-level
resistance to ciprofloxacin (MIC
1 µg/ml), while none of the
27 strains from 1981 to 1984 showed high-level resistance to
ciprofloxacin. The proportions of the 1997-1998 strains showing high-level resistance to norfloxacin (MIC
2 µg/ml),
levofloxacin (MIC
0.5 µg/ml), sparfloxacin (MIC
0.5 µg/ml), and DU-6859a (MIC
0.25 µg/ml) were 32.5, 28.7, 21.7, and 8.3%, respectively. On the other hand, none or only one of
the 27 isolates from 1981 to 1984 were highly resistant to these
fluoroquinolones (Table 1). These
differences in prevalence of high-level resistance to the five
fluoroquinolones between the strains from 1997-1998 and those from
1981 to 1984 were statistically significant (P < 0.0001). In the present study, the emergence of high-level
resistance not only to older fluoroquinolones such as norfloxacin and
ciprofloxacin but also to newer ones such as levofloxacin and
sparfloxacin was found in N. gonorrhoeae isolates obtained
in 1997-1998 in Fukuoka City. However, no significant reductions in
the susceptibilities of the 1997-1998 strains to
-lactams,
tetracycline, azithromycin, or spectinomycin were observed.
 |
FOOTNOTES |
*
Phone: 81-92-642-5603
Fax: 81-92-642-5618
E-mail: masatosh{at}uro.med.kyushu-u.ac.jp
 |
REFERENCES |
| 1.
|
Handsfield, H. H., and W. L. Whittington.
1996.
Antibiotic-resistant Neisseria gonorrhoeae: the calm before another storm?
Ann. Intern. Med.
125:507-509[Free Full Text].
|
| 2.
|
Tanaka, M.,
T. Matsumoto,
I. Kobayashi,
U. Uchino, and J. Kumazawa.
1995.
Emergence of in vitro resistance to fluoroquinolones in Neisseria gonorrhoeae isolated in Japan.
Antimicrob. Agents Chemother.
39:2367-2370[Abstract].
|
| | | | |
Masatoshi Tanaka*
Seiji Naito
Department of Urology Faculty of Medicine Kyushu University 3-1-1, Maidashi Higashi-ku, Fukuoka 812-8582 Japan
|
| | | | |
Hiroshi Nakayama
Nakayama Urologic Clinic Fukuoka, Japan
|
| | | | |
Intetsu Kobayashi
Division of Chemotherapy Mitsubishi kagaku BCL Tokyo, Japan
|
Antimicrobial Agents and Chemotherapy, March 1999, p. 722-723, Vol. 43, No. 3
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.